IPerGlio kick-off meeting, 13^th June 2023, Oslo, Norway

Above from left to right: Roberto Pallini and Ruben Sakowsky. Bottom from left to right: Nadia Mensali, Lyazid Drissi Yahyaoui, Gabriele Lucia, Quintino Giorgio D'alessandris, Else Marit Inderberger, Antonio Cosma, Sébastien Walchli, Einar Vik-Mo, Marcos J. Araúzo-Bravo and Daniela Gerovska.

The IPerGlio kick-off meeting took place on Tuesday 13^th of June 2023 at Oslo University Hospital-Norwegian Radium Hospital. The meeting was chaired by Else Marit Inderberger.

During the meeting the members of the consortium were introduced, and the main topics of the project were discussed. As a result of the kick-off meeting, the most important guidelines for the first steps of the project were established, as well as other plans to ensure the success of the project in the future.

IPerGlio 2^nd Annual meeting, June 10-11, 2024, Rome, Italy

The 2^nd annual meeting of IPerGlio was held on 10-11 of June 2024 at the Instituto Supeiore di Sanita (ISS), Rome, Italy. The meeting was chaired by Else Marit Inderberger and Lucia Gabriele.

During this meeting, the members of the consortium presented the main results and discussed the management of the data presentation and planing of the IPerGlio project.

In addition, conference with a series of presentations entitled

"Exploring novel data strategies for immuno-oncology".

were held on 11 June.

Organized by

• Istitute Superiore Di Sanità (ISS) Rome, Italy.
• Department of Oncology and Molecular Medicine.
• Foundazione Policlinico Agostino Gemelli (FPG).

The presentations were open to all ISS staff and members of the scientific community in Rome.

Rationale

Building on the IPerGlio project, which aims to identify crucial prognostic markers for glioblastoma (GBM) to quide therapeutic decisions. This event presented updates on the latest scientific advancements in data production and management in the field of immmuno-oncology. The IPerGlio project integrates clinical and immune parameters -including phenottypical, molecular functional, and imaging data -from 260 patients, along with Lifestyle/Environmental (LE) factors data, using Business Intelligence (BI) techniques and Artificial Intellgence (AI) algorithms.

Objectives

To create and actively support and international collaborative network of scientists with specific expertise in immuno-oncology

Presentations

• Business Intelligence applications in immonology.

  Antonio Cosma. Luxembourg Institute of Health (LIH), Luxembourg.

• Towards the application of artificial intelligence to extrachromosomal circular DNA-based diagnostics.

  Marcos J. Araúzo-Bravo. Biogipuzkoa Health Research Institute (BHRI), Donostia/San-Sebastián, Spain.

• When cops become robbers: T and B cells in autoimmune and leukemia.

  Mario Picozza. Neuroimmunology Unit. IRCSS Foundazione Santa Lucia, Italy.

• Immune correlates of response to immunotherapy in glioblastoma.

  Else Marit Inderberg. Oslo University Hospital (OUH). Norwegian Radium Hospital, Oslo, Norway.

• Inflammation and DNA damage: cause, effect, or both.

  Vittorio Enrico Avvedimento. University Federico II, Napoli, Italy.

Chairs

• Lucia Gabriele. Italian Institute of Health (ISS), Rome, Italy.
• Giorgio D'Alessandris. Agostino Gemelli University Polyclinic Foundation (IRCCS), Rome, Italy.

Scientific coordinators

• Lucia Gabriele. Italian Institute of Health (ISS), Rome, Italy.
• Roberto Pallini. Departament of Neurosurgery. Agostino Gemelli University Polyclinic Foundation (IRCCS), Rome, Italy.
• Giorgio D'Alessandris. Departament of Neurosurgery. Agostino Gemelli University Polyclinic Foundation (IRCCS), Rome, Italy.

Scientific secretariat

• Sara Gualdi. Department of Oncology and Molecular Medicine. Italian Institute of Health (ISS), Rome, Italy.
• Simona Donati. Department of Oncology and Molecular Medicine. Italian Institute of Health (ISS), Rome, Italy.
• Liverana Lauretti. Department of Neurosurgery. Agostino Gemelli University Polyclinic Foundation (IRCCS) (FPG), Rome, Italy.
• Martina Offi. Department of Neurosurgery. Agostino Gemelli University Polyclinic Foundation (IRCCS) (FPG), Rome, Italy.

Organizing secretariat

• Irene Canini. Department of Oncology and Molecular Medicine. Italian Institute of Health (ISS), Rome, Italy.
• Mariangela Fontana. Department of Oncology and Molecular Medicine. Italian Institute of Health (ISS), Rome, Italy.

• Stefano Guida. Department of Oncology and Molecular Medicine. Italian Institute of Health (ISS), Rome, Italy.

IPerGlio 3^nd Annual meeting, May 19-20, 2025, San Sebastian, Spain

The 3^nd annual meeting of IPerGlio was held on 19-20 of May 2025 at Biogipuzkoa Health Resesearch Institute (BHRI), San Sebastian, Spain. The meeting was chaired by Else Marit Inderberger and Marcos J. Araúzo-Bravo.

During this meeting, the members of the consortium presented the main results and discussed the management of the data presentation and planing of the IPerGlio project.